Table 1 Descriptive table of 2819 ER-positive breast cancer cases by Scottish Index for Multiple Deprivation (SIMD) diagnosed in Scotland from 2007–2008
Variable | Categories of variable | Total Patients (N = 2819) (Column %) | SIMD 1 (least deprived) (N = 767) | SIMD 2 (N = 661) | SIMD 3 (N = 601) | SIMD 4 (N = 496) | SIMD 5 (most deprived) (N = 294) |
|---|---|---|---|---|---|---|---|
Event type | Dead, no recurrence | 438 (15.5%) | 99 (12.9%) | 107 (16.2%) | 91 (15.1%) | 89 (17.9%) | 52 (17.7%) |
Alive, no recurrence | 1958 (69.5%) | 547 (71.3%) | 456 (69.0%) | 413 (68.7%) | 346 (69.8%) | 196 (66.7%) | |
Recurrence (+/− death following recurrence) | 423 (15.0%) | 121 (15.8%) | 98 (14.8%) | 97 (16.1%) | 61 (12.3%) | 46 (15.6%) | |
Cause of deatha | Breast cancer | 249 (36.2%) | 70 (40.5%) | 48 (31.8%) | 49 (34.8%) | 44 (33.3%) | 38 (41.8%) |
Non breast cancer death | 319 (46.4%) | 76 (43.9%) | 65 (43.0%) | 59 (41.8%) | 73 (55.3%) | 46 (50.5%) | |
Tumour grade | Grade 1 | 483 (17.1%) | 134 (17.5%) | 105 (15.9%) | 91 (15.1%) | 96 (19.4%) | 57 (19.4%) |
Grade 2 | 1516 (53.8%) | 424 (55.3%) | 360 (54.5%) | 333 (55.4%) | 264 (53.2%) | 135 (45.9%) | |
Grade 3 | 788 (28.0%) | 201 (26.2%) | 187 (28.3%) | 170 (28.3%) | 133 (26.8%) | 97 (33.0%) | |
TNM stage | I | 1088 (53.4%) | 316 (55.0%) | 235 (53.4%) | 221 (54.8%) | 206 (53.2%) | 110 (47.0%) |
II | 790 (38.7%) | 211 (36.7%) | 177 (40.2%) | 143 (35.5%) | 151 (39.0%) | 108 (46.2%) | |
III | 161 (7.9%) | 48 (8.3%) | 268 (6.4%) | 39 (9.7%) | 30 (7.8%) | 16 (6.8%) | |
Age at diagnosis | < 50 | 580 (20.6%) | 147 (19.2%) | 132 (20.0%) | 142 (23.6%) | 102 (20.6%) | 57 (19.4%) |
50–70 | 1603 (56.9%) | 442 (57.6%) | 374 (56.6%) | 343 (57.1%) | 276 (55.6%) | 168 (57.1%) | |
70 + | 636 (22.6%) | 178 (23.2%) | 155 (23.4%) | 116 (19.3%) | 118 (23.8%) | 69 (23.5%) | |
Treatment received | Breast-conserving surgery | 1726 (61.2%) | 498 (64.9%) | 395 (59.8%) | 366 (60.9%) | 288 (58.1%) | 179 (60.9%) |
Mastectomy | 1093 (38.8%) | 269 (35.1%) | 266 (40.2%) | 235 (39.1%) | 208 (41.9%) | 115 (39.1%) | |
Chemotherapy | 1087 (38.6%) | 291 (38.0%) | 248 (37.6%) | 238 (39.7%) | 187 (37.8%) | 123 (41.8%) | |
Radiotherapy | 2089 (74.4%) | 584 (76.3%) | 462 (70.0%) | 450 (75.4%) | 369 (74.7%) | 224 (76.5%) | |
Screeningb | Screen detected | 969 (60.4%) | 262 (59.3%) | 232 (62.0%) | 215 (62.7%) | 162 (58.7%) | 98 (58.3%) |
Not screen detected | 634 (39.6%) | 180 (40.7%) | 388 (38.0%) | 366 (37.3%) | 301 (41.3%) | 189 (41.7%) |